赛升药业：马丽刘淑芹3个月内减持2%

Group 1 - The company Saisheng Pharmaceutical announced that two shareholders, Ma Li and Liu Shuqin, hold 29.8468 million shares and 8.748 million shares, representing 6.2% and 1.82% of the total shares respectively [1] - The shareholders plan to reduce their holdings by a total of no more than 9.6333 million shares, which is up to 2% of the total shares, between October 21, 2025, and January 20, 2026 [1] - The reduction will be executed through centralized bidding and block trading, with each method accounting for no more than 4.8167 million shares, or 1% of the total shares [1]